Omega-3 fatty acids induce cell deathω3-polyunsaturated fatty acids induce cell death through apoptosis and autophagy in glioblastoma cells: In vitro and in vivo.
We delved into the potential of omega-3 polyunsaturated fatty acids, specifically docosahexaenoic acid (DHA), to combat glioblastoma, one of the most aggressive brain tumors.
In our study, we found that DHA treatment led to cell death in glioblastoma cells, as evidenced by signs of apoptosis and increased autophagy. Furthermore, tests in transgenic mice revealed a notable reduction in tumor size and increased activity reflected in cell death markers.
While these findings suggest a promising avenue for GBM treatment, further research is needed to fully understand how omega-3 fatty acids could be integrated into cancer therapies.
Read More
Omega-3 liposomes reduce tumor viabilityMicrofluidic-derived docosahexaenoic acid liposomes for glioblastoma therapy.
We investigated the potential of docosahexaenoic acid (DHA) liposomes in treating glioblastoma, a challenging type of brain tumor. Using an advanced microfluidic system, we created liposomes that effectively penetrated GBM cells.
The results were promising; the DHA liposomes not only reduced tumor cell viability but also initiated cell death more effectively than regular DHA. This study opens new avenues for cancer treatment using omega-3 fatty acids in liposome formulations, highlighting their potential as a valuable therapeutic strategy.
Read More
Omega-3 effects on glioblastoma cellsFABP7 Facilitates Uptake of Docosahexaenoic Acid in Glioblastoma Neural Stem-like Cells.
We explored the potential of omega-3 fatty acid, docosahexaenoic acid (DHA), to combat glioblastoma, an aggressive brain tumor. By studying patient-derived GBM neural stem-like cells, we found that DHA treatment increases its levels in these cells, assisted by a protein called FABP7. This increase in DHA was linked to a reduction in the cells' ability to migrate, suggesting a possible therapeutic approach to limit tumor spread. However, more research is needed to fully understand the implications of DHA on glioblastoma treatment.
Read More
Omega-3 may aid olfactory recoveryEffect of Omega-3 Supplementation in Patients With Smell Dysfunction Following Endoscopic Sellar and Parasellar Tumor Resection: A Multicenter Prospective Randomized Controlled Trial.
We explored how omega-3 fish oil supplementation might support smell recovery in patients after endoscopic brain tumor surgery. In a multicenter trial involving 110 patients, those receiving omega-3 alongside nasal saline experienced less persistent loss of smell compared to peers without it.
Significantly, fewer patients in the omega-3 group reported olfactory issues at three and six months post-surgery. This suggests that omega-3 could play a protective role for the olfactory system during the recovery phase. However, surgery type also influenced outcomes.
Read More
Curcumin-DHA shows potential for glioblastomaDocosahexaenoic acid-mediated, targeted and sustained brain delivery of curcumin microemulsion.
We explored a new formulation combining curcumin and docosahexaenoic acid (DHA) for treating brain tumors. By using microemulsions, this treatment showed impressive ability to penetrate the blood-brain barrier.
After administration, the curcumin concentrations in the brain were significantly higher—as much as 66 times greater compared to standard solutions. This suggests the potential of curcumin with DHA for effectively targeting glioblastoma brain cancer. Safety tests indicated that this approach does not harm surrounding tissues, highlighting its promising anticancer effects.
Read More